AI Drug Design with Generative Models: From VAEs and GANs to Diffusion, Honestly Explained

By BioDockify Computational Research Team · October 17, 2026 · AI & Machine Learning

How generative AI actually designs molecules: VAEs learning chemical space, GANs and RL, the diffusion wave, famous validations like Insilico\\'s DDR1 kinase inhibitor, and the honest limits - what these models generate, verify, and still cannot.

Read the complete article with tables, code and references on BioDockify.

Key References

• Zhavoronkov, A. et al. Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nat. Biotechnol. 37, 1038-1040 (2019). DOI: 10.1038/s41587-019-0247-3
• Gomez-Bombarelli, J. et al. Automatic chemical design using a data-driven continuous representation of molecules. ACS Cent. Sci. 4, 268-276 (2018). DOI: 10.1021/acscentsci.7b00572
• Corso, G., St"ark, H., Jing, B., Barzilay, R. & Jaakkola, T. DiffDock. ICLR (2023). arXiv:2210.01776
• Segler, M.H.A., Kogej, T., Tyrchan, C. & Waller, M.P. Generating focused molecule libraries by deep reinforcement learning. ACS Cent. Sci. 4, 120-131 (2018).

Scope & Limitations

Generated molecules are hypotheses: synthetic accessibility and activity remain unverified until made and tested - generation is the cheapest step Benchmark metrics for generative models (novelty, validity) measure chemistry-plausibility, not usefulness; the field's hardest problem is multi-objective optimization